BCI
IMCR icon

Brinker Capital Investments’s Immunocore IMCR Stock Holding History

Brinker Capital Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,524
Closed -$619K – 2014
2026
Q1 		$619K Sell
20,524
-1,476
-7% -$47.8K 0.01% 1359
2025
Q4 		$764K Sell
22,000
-1,276
-5% -$45K 0.01% 1374
2025
Q3 		$846K Sell
23,276
-689
-3% -$23.4K 0.01% 1306
2025
Q2 		$752K Buy
23,965
+1,031
+4% +$32K 0.01% 1341
2025
Q1 		$680K Buy
22,934
+9,917
+76% +$297K 0.01% 1260
2024
Q4 		$384K Sell
13,017
-7,675
-37% -$243K ﹤0.01% 1443
2024
Q3 		$644K Sell
20,692
-2,282
-10% -$83K 0.01% 1238
2024
Q2 		$779K Sell
22,974
-153
-0.7% -$7.8K 0.01% 1092
2024
Q1 		$1.5M Buy
23,127
+5,826
+34% +$400K 0.02% 793
2023
Q4 		$1.2M Sell
17,301
-3,248
-16% -$169K 0.01% 869
2023
Q3 		$1.07M Buy
20,549
+4,645
+29% +$275K 0.01% 905
2023
Q2 		$954K Buy
+15,904
New +$908K 0.01% 974

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Brinker Capital Investments's IMCR Position: Q2 2026 in Review

Brinker Capital Investments sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 20,524 shares — an estimated $619K sold.

Brinker Capital Investments first reported a position in IMCR in Q2 2023 and held it in 12 quarters. The position peaked at $1.5M in Q1 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Brinker Capital Investments reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Brinker Capital Investments sold 20,524 Immunocore shares in Q2 2026, an estimated $619K.
  • Brinker Capital Investments first reported a position in Immunocore in Q2 2023 and held it in 12 quarters.
  • Brinker Capital Investments's Immunocore position peaked at $1.5M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.